piboserod has been researched along with ml 10302 in 1 studies
Studies (piboserod) | Trials (piboserod) | Recent Studies (post-2010) (piboserod) | Studies (ml 10302) | Trials (ml 10302) | Recent Studies (post-2010) (ml 10302) |
---|---|---|---|---|---|
119 | 5 | 53 | 31 | 0 | 11 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cachard-Chastel, M; Croes, S; Deloménie, C; Devijver, H; Dewachter, I; Gardier, AM; Langlois, M; Lezoualc'h, F; Sicsic, S; Van Leuven, F | 1 |
1 other study(ies) available for piboserod and ml 10302
Article | Year |
---|---|
5-HT4 receptor agonists increase sAPPalpha levels in the cortex and hippocampus of male C57BL/6j mice.
Topics: Aminobenzoates; Amyloid beta-Protein Precursor; Animals; Benzofurans; Cerebral Cortex; Cholinesterase Inhibitors; Donepezil; Hippocampus; Indans; Indoles; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; para-Aminobenzoates; Piperidines; RNA, Messenger; Serotonin 5-HT4 Receptor Agonists; Serotonin 5-HT4 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists; Sulfonamides | 2007 |